http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0050074-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4acae202b6a15394281949545e70d2f6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N53-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-74
filingDate 1981-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00d7b6625d40e1708cc0329e6cd25606
publicationDate 1982-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0050074-A2
titleOfInvention Methyl esters of 2,2-dimethyl cyclopropane-1,3-dicarboxylic acid, their preparation and intermediales obtained
abstract The subject of the invention is the compounds corresponding to formula (1): of cis or trans configuration, in their optically active forms, as well as their preparation by resolution of the mono methyl ester of acid (1 RS, 3SR) cis 2,2-dimethyl cyclopropane 1,3-dicarboxylic using (d) or (1) a-methyl benzylamine and possible isomerization by the action of a strong base.n n n The invention also relates to the new intermediaries obtained.n n n Compounds (I) are intermediates in the synthesis of chrysanthemic esters.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0226043-A1
priorityDate 1980-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128641869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID179449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68115087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393271
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7669
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129165959
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226444315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128891415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129044226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393439
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12708724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7504
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1068
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11715199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129706288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229406688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128030093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128047903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128218335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128966575
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227532710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235642602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127830662
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID263764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128218336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69017

Total number of triples: 51.